These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4314431)

  • 1. The role of the serologic type in experimental immunity against B. Pertussis.
    Pusztai Z; Joó I
    Prog Immunobiol Stand; 1967; 3():309-14. PubMed ID: 4314431
    [No Abstract]   [Full Text] [Related]  

  • 2. Pitfalls in the preparation of monotypic agglutinating antisera for Bordetella pertussis.
    Holt LB
    J Med Microbiol; 1968 Nov; 1(2):169-80. PubMed ID: 4318535
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments on the immunizing capicity of B. pertussin serotypes.
    Andreescu V; Caffé I; Marion M; Ivan I
    Arch Roum Pathol Exp Microbiol; 1977; 36(2):107-14. PubMed ID: 209764
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological types of whooping cough bacteria and their connection with immunity in vaccinated children.
    Demina AA; Devyatkina NP; Voloshina LZ; Larina LI; Semina NA; Venglinskaya EA; Kostyukova KP
    J Hyg Epidemiol Microbiol Immunol; 1973 Mar; 17(3):304-15. PubMed ID: 4355335
    [No Abstract]   [Full Text] [Related]  

  • 7. The relevance of agglutinogenic types of Bordetella pertussis in the assay of pertussis vaccines.
    Cameron J
    Prog Immunobiol Stand; 1967; 3():302-8. PubMed ID: 4314430
    [No Abstract]   [Full Text] [Related]  

  • 8. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
    Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
    Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
    [No Abstract]   [Full Text] [Related]  

  • 9. Essential immunogens in human pertussis: the role of fimbriae.
    Preston NW
    Dev Biol Stand; 1985; 61():137-41. PubMed ID: 2872099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotype specificity of vaccine-induced immunity to pertussis.
    Preston NW; Carter EJ
    Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R155-6. PubMed ID: 1285135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive and active immunity in whooping-cough in youngest children.
    Pstragowska W
    Pol Med J; 1966; 5(5):1103-8. PubMed ID: 5958797
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serotyping of recently isolated strains of Bordetella pertussis. II. Disparity of agglutination titers of patients' sera between antigens prepared from the Maeno and recently isolated strains (author's transl)].
    Sekiya K; Yamada M; Takamiya A; Nakase Y
    Nihon Saikingaku Zasshi; 1979 Nov; 34(6):827-35. PubMed ID: 231129
    [No Abstract]   [Full Text] [Related]  

  • 13. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and simple method for evaluation of serum opsonic capacity against Bordetella pertussis by chemiluminescence.
    Lilius EM; Mertsola J; Leivo P; Kuronen T; Ruuskanen O
    Dev Biol Stand; 1985; 61():373-7. PubMed ID: 2872125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Restriction analysis of Bordetella pertussis DNA isolated from patients with whooping cough in 1968 and 1995-98 and B. pertussis used for production of national vaccine strains].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 2000; 52(2):111-7. PubMed ID: 11107785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sequence of enhanced cellular activity and protective humoral factors in murine pertussis immunity.
    Gray DF; Cheers C
    Immunology; 1969 Dec; 17(6):889-96. PubMed ID: 4318530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indices of the strength of collective pertussis immunity].
    Ryzhenko IM; Verezub LG; Vil'vovskaia RI; Tigraniants VN; Dubova ON
    Vrach Delo; 1981 Jul; (7):111-4. PubMed ID: 6269302
    [No Abstract]   [Full Text] [Related]  

  • 18. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec.
    Knowles K; Lorange M; Matthews RC; Preston NW
    Can Commun Dis Rep; 1993 Nov; 19(21):182-3, 186-7. PubMed ID: 8298581
    [No Abstract]   [Full Text] [Related]  

  • 20. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.